The APOE ε2 allele may decrease the age at onset in patients with spinocerebellar ataxia type 3 or Machado-Joseph disease from the Chinese Han population

Neurobiology of Aging

Volumn 35, Issue 9, 2014, Pages 2179.e15-2179.e18

  Peng, Huirong ^a   Wang, Chunrong ^a   Chen, Zhao ^a   Sun, Zhanfang ^a   Jiao, Bin ^a   Li, Kai ^a   Huang, Fengzhen ^a   Hou, Xuan ^a   Wang, Junling ^a,b   Shen, Lu ^a,b   Xia, Kun ^b   Tang, Beisha ^a,b   Jiang, Hong ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Alleles; APOE gene; ATXN3 gene; Genotypes; SCA3 MJD

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 2; UNCLASSIFIED DRUG; APOLIPOPROTEIN E2; ATXN3 PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN; REPRESSOR PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; ATXN3 GENE; CAG REPEAT; CASE CONTROL STUDY; CHINESE; CHINESE HAN; COHORT ANALYSIS; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; GENE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MACHADO JOSEPH DISEASE; MAJOR CLINICAL STUDY; MALE; MJD GENE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SCA3 GENE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; GENE FREQUENCY; GENETICS; HETEROZYGOTE; MACHADO-JOSEPH DISEASE; MIDDLE AGED; TRINUCLEOTIDE REPEAT; YOUNG ADULT;

ADULT; AGE OF ONSET; AGED; ALLELES; APOLIPOPROTEIN E2; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HETEROZYGOTE; HUMANS; MACHADO-JOSEPH DISEASE; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; REPRESSOR PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION; YOUNG ADULT;

EID: 84902079933     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.03.020     Document Type: Article

References (38)

1. Bettencourt C., Raposo M., Kazachkova N., Cymbron T., Santos C., Kay T., Vasconcelos J., Maciel P., Donis K.C., Saraiva-Pereira M.L., Jardim L.B., Sequeiros J., Lima M. The APOE epsilon2 allele increases the risk of earlier age at onset in Machado-Joseph disease. Arch. Neurol. 2011, 68:1580-1583.
2. Boardman J.D., Barnes L.L., Wilson R.S., Evans D.A., Mendes D.L.C. Social disorder, APOE-E4 genotype, and change in cognitive function among older adults living in Chicago. Soc. Sci. Med. 2012, 74:1584-1590.
3. Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J.Clin. Invest. 1985, 76:1501-1513.
4. Cardin A.D., Bowlin T.L., Krstenansky J.L. Inhibition of lymphocyte proliferation by synthetic peptides homologous to human plasma apolipoproteins B and E. Biochem. Biophys. Res. Commun. 1988, 154:741-745.
5. Carvalho D.R., La Rocque-Ferreira A., Rizzo I.M., Imamura E.U., Speck-Martins C.E. Homozygosity enhances severity in spinocerebellar ataxia type 3. Pediatr. Neurol. 2008, 38:296-299.
6. Chapman J., Korczyn A.D., Karussis D.M., Michaelson D.M. The effects of APOE genotype on age at onset and progression of neurodegenerative diseases. Neurology 2001, 57:1482-1485.
7. Costa M.C., Paulson H.L. Toward understanding Machado-Joseph disease. Prog. Neurobiol. 2012, 97:239-257.
8. Handelmann G.E., Boyles J.K., Weisgraber K.H., Mahley R.W., Pitas R.E. Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons invitro. J.Lipid Res. 1992, 33:1677-1688.
9. Hatters D.M., Peters-Libeu C.A., Weisgraber K.H. Apolipoprotein E structure: insights into function. Trends Biochem. Sci. 2006, 31:445-454.
10. Inzelberg R., Chapman J., Treves T.A., Asherov A., Kipervasser S., Hilkewicz O., Verchovsky R., Klimowitzky S., Korczyn A.D. Apolipoprotein E4 in Parkinson disease and dementia: new data and meta-analysis of published studies. Alzheimer Dis. Assoc. Disord. 1998, 12:45-48.
11. Jiang H., Tang B.S., Xu B., Zhao G.H., Shen L., Tang J.G., Li Q.H., Xia K. Frequency analysis of autosomal dominant spinocerebellar ataxias in mainland Chinese patients and clinical and molecular characterization of spinocerebellar ataxia type 6. Chin. Med. J. (Engl) 2005, 118:837-843.
12. Kawaguchi Y., Okamoto T., Taniwaki M., Aizawa M., Inoue M., Katayama S., Kawakami H., Nakamura S., Nishimura M., Akiguchi I., Et A. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 1994, 8:221-228.
13. Kehoe P., Krawczak M., Harper P.S., Owen M.J., Jones A.L. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. J.Med. Genet. 1999, 36:108-111.
14. Maciel P., Costa M.C., Ferro A., Rousseau M., Santos C.S., Gaspar C., Barros J., Rouleau G.A., Coutinho P., Sequeiros J. Improvement in the molecular diagnosis of Machado-Joseph disease. Arch. Neurol. 2001, 58:1821-1827.
15. Maraganore D.M., Farrer M.J., Hardy J.A., McDonnell S.K., Schaid D.J., Rocca W.A. Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease. Mov. Disord. 2000, 15:714-719.
16. Miller S.A., Dykes D.D., Polesky H.F. Asimple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
17. Miyata M., Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 1996, 14:55-61.
18. Moseley M.L., Benzow K.A., Schut L.J., Bird T.D., Gomez C.M., Barkhaus P.E., Blindauer K.A., Labuda M., Pandolfo M., Koob M.D., Ranum L.P. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology 1998, 51:1666-1671.
19. Mukherjee A., Arnaud L., Cooper J.A. Lipid-dependent recruitment of neuronal Src to lipid rafts in the brain. J.Biol. Chem. 2003, 278:40806-40814.
20. Paulson H. Machado-Joseph disease/spinocerebellar ataxia type 3. Handb. Clin. Neurol. 2012, 103:437-449.
21. Posse D.C.E., Vance D.E., Campenot R.B., Kiss R.S., Vance J.E. Uptake of lipoproteins for axonal growth of sympathetic neurons. J.Biol. Chem. 2000, 275:19883-19890.
22. Rapp A., Gmeiner B., Huttinger M. Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes. Biochimie 2006, 88:473-483.
23. Rhinn H., Fujita R., Qiang L., Cheng R., Lee J.H., Abeliovich A. Integrative genomics identifies APOE epsilon4 effectors in Alzheimer's disease. Nature 2013, 500:45-50.
24. Saft C., Andrich J.E., Brune N., Gencik M., Kraus P.H., Przuntek H., Epplen J.T. Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease. J.Neurol. Neurosurg. Psychiatry 2004, 75:1692-1696.
25. Sando S.B., Melquist S., Cannon A., Hutton M.L., Sletvold O., Saltvedt I., White L.R., Lydersen S., Aasly J.O. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. BMC Neurol. 2008, 8:9.
26. Schipper H.M. Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment. Neurobiol. Aging 2011, 32:778-790.
27. Schols L., Amoiridis G., Epplen J.T., Langkafel M., Przuntek H., Riess O. Relations between genotype and phenotype in German patients with the Machado-Joseph disease mutation. J.Neurol. Neurosurg. Psychiatry 1996, 61:466-470.
28. Schols L., Amoiridis G., Langkafel M., Buttner T., Przuntek H., Riess O., Vieira-Saecker A.M., Epplen J.T. Machado-Joseph disease mutations as the genetic basis of most spinocerebellar ataxias in Germany. J.Neurol. Neurosurg. Psychiatry 1995, 59:449-450.
29. Sequeiros J., Coutinho P. Epidemiology and clinical aspects of Machado-Joseph disease. Adv. Neurol. 1993, 61:139-153.
30. Siest G., Pillot T., Regis-Bailly A., Leininger-Muller B., Steinmetz J., Galteau M.M., Visvikis S. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin. Chem. 1995, 41:1068-1086.
31. Tang B., Liu C., Shen L., Dai H., Pan Q., Jing L., Ouyang S., Xia J. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch. Neurol. 2000, 57:540-544.
32. van Alfen N., Sinke R.J., Zwarts M.J., Gabreels-Festen A., Praamstra P., Kremer B.P., Horstink M.W. Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype. Ann. Neurol. 2001, 49:805-807.
33. van de Warrenburg B.P., Hendriks H., Durr A., van Zuijlen M.C., Stevanin G., Camuzat A., Sinke R.J., Brice A., Kremer B.P. Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort. Ann. Neurol. 2005, 57:505-512.
34. van de Warrenburg B.P., Sinke R.J., Verschuuren-Bemelmans C.C., Scheffer H., Brunt E.R., Ippel P.F., Maat-Kievit J.A., Dooijes D., Notermans N.C., Lindhout D., Knoers N.V., Kremer H.P. Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis. Neurology 2002, 58:702-708.
35. Wang Y.G., Du J., Wang J.L., Chen J., Chen C., Luo Y.Y., Xiao Z.Q., Jiang H., Yan X.X., Xia K., Pan Q., Tang B.S., Shen L. Six cases of SCA3/MJD patients that mimic hereditary spastic paraplegia in clinic. J.Neurol. Sci. 2009, 285:121-124.
36. Weisgraber K.H., Rall S.J., Mahley R.W. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J.Biol. Chem. 1981, 256:9077-9083.
37. Wierenga C.E., Dev S.I., Shin D.D., Clark L.R., Bangen K.J., Jak A.J., Rissman R.A., Liu T.T., Salmon D.P., Bondi M.W. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition. J.Cereb. Blood Flow Metab. 2012, 32:1589-1599.
38. Zareparsi S., Camicioli R., Sexton G., Bird T., Swanson P., Kaye J., Nutt J., Payami H. Age at onset of Parkinson disease and apolipoprotein E genotypes. Am. J. Med. Genet. 2002, 107:156-161.